Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
2,318,480 6.300% |
409,969 (+21.48%) |
Filing History |
| 2025-02-10 5:06 pm Purchase |
2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 3,633,333 9.200% |
3,633,333 (New Position) |
Filing History |
| 2025-02-05 5:28 pm Purchase |
2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,908,511 5.300% |
22,495 (+1.19%) |
Filing History |
| 2025-01-30 9:58 pm Purchase |
2024-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 1,673,587 4.640% |
1,673,587 (New Position) |
Filing History |
| 2024-12-23 8:08 pm Purchase |
2024-12-17 | 13G | Inovio Pharmaceuticals, Inc. INO |
Stonepine Capital Management, LLC | 1,916,666 5.200% |
1,916,666 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,886,016 7.300% |
0 (Unchanged) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,886,016 7.300% |
1,886,016 (New Position) |
Filing History |
| 2024-04-26 4:01 pm Purchase |
2024-04-16 | 13G | Inovio Pharmaceuticals, Inc. INO |
Deep Track Capital, LP | 2,593,822 9.990% |
2,593,822 (New Position) |
Filing History |
| 2024-02-13 5:06 pm Purchase |
2023-12-29 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 19,766,042 7.240% |
18,345,834 (+1291.77%) |
Filing History |
| 2024-01-22 10:20 am Sale |
2023-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
STATE STREET CORP STT |
72,587 0.320% |
-533 (-0.73%) |
Filing History |
| 2023-07-10 2:07 pm Sale |
2023-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
STATE STREET CORP STT |
73,121 0.330% |
-2,549,575 (-97.21%) |
Filing History |
| 2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
507,219 2.300% |
-1,433,125 (-73.86%) |
Filing History |
| 2023-02-09 3:11 pm Purchase |
2022-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
STATE STREET CORP STT |
2,622,696 12.610% |
683,702 (+35.26%) |
Filing History |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 1,420,208 6.830% |
500,266 (+54.38%) |
Filing History |
| 2023-01-24 1:56 pm Purchase |
2022-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,940,343 9.300% |
419,934 (+27.62%) |
Filing History |
| 2022-04-11 2:07 pm Purchase |
2022-03-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
STATE STREET CORP STT |
1,938,994 10.490% |
830,625 (+74.94%) |
Filing History |
| 2022-02-11 11:41 am Purchase |
2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
STATE STREET CORP STT |
1,108,369 6.320% |
367,156 (+49.53%) |
Filing History |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
The Vanguard Group | 919,943 5.250% |
154,473 (+20.18%) |
Filing History |
| 2022-02-01 5:08 pm Purchase |
2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
BLACKROCK INC BLK |
1,520,410 8.700% |
333,498 (+28.10%) |
Filing History |
| 2021-02-11 4:03 pm Sale |
2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO |
Nikko Asset Management Americas, Inc. | 0 0.000% |
-420,634 (Position Closed) |
Filing History |